A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma

A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma

Abstract Background Preoperative chemoradiotherapy (CRT) followed by surgery is the most common approach for patients with resectable esophageal cancer. Nevertheless, considerable numbers of esophageal-cancer patients undergo surgery as the first treatment. The benefit of neoadjuvant therapy might o...

Full description

Bibliographic Details
Main Authors: Wenjie Ni, Shufei Yu, Wencheng Zhang, Zefen Xiao, Zongmei Zhou, Dongfu Chen, Qinfu Feng, Jun Liang, Jima Lv, Shugeng Gao, Yousheng Mao, Qi Xue, Kelin Sun, Xiangyang Liu, Dekang Fang, Jian Li, Dali Wang
Format: Article
Language:English
Published: BMC 2020-02-01
Series:BMC Cancer
Subjects:
Esophageal cancer
Adjuvant therapy
Chemoradiotherapy
Surgery
Online Access:http://link.springer.com/article/10.1186/s12885-020-6592-2

Internet

http://link.springer.com/article/10.1186/s12885-020-6592-2

Similar Items